Ficlatuzumab

Tax included
Ficlatuzumab is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF). Ficlatuzumab blocks the activation of the HGF/c-Met signaling pathway, and inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion.
MedChemExpress 
HY-P99196

Data sheet

Size
Multiple sizes
Reactivity
c-Met/HGFR
Application
Cancer-Kinase/protease
CAS
1174900-84-5